Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Neuregulin 1 as a potential biomarker for disease progression in moyamoya disease: A case-control study in Chinese population.

Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association - 1 Mar 2024

Chen Jie, Zheng Hanyue, Wu Xiaoxin, Niu Xingyang, Dai Yuanyuan, Zhou Zhenhua, Ye Fei

Abstract excerpt

OBJECTIVE: Moyamoya disease (MMD) is a rare and progressive stenosis of cerebral arteries characterized by abnormally proliferative vasculopathy. Current studies have demonstrated that Neuregulin 1 (NRG1) plays a key role in angiogenesis-related disorders. Thus, the aim of our study is to investigate the serum NRG1 levels and their clinical correlations in MMD patients. METHODS: In this study, thirty adult...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenosine Triphosphatases
Share to Biomarkers

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Case-Control Studies

Share to Disease Progression

Share to Moyamoya Disease

Share to Neuregulin-1

Share to Ubiquitin-Protein Ligases

Source

Identifiers

PMID: 38224792
DOI: 10.1016/j.jstrokecerebrovasdis.2024.107581

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Neuregulin 1 as a potential biomarker for disease progression in moyamoya disease: A case-control study in Chinese population.PMID 38224792Read ↗

Research Progresses in Understanding the Pathophysiology of Moyamoya Disease.Semantic proximity Read ↗

The Susceptibility Pathogenesis of Moyamoya Disease.Semantic proximity Read ↗

Meta-analysis of the association between RNF213 polymorphisms and clinical features of moyamoya disease in Asian population.Semantic proximity Read ↗

RNF213-Related Vasculopathy: Various Systemic Vascular Diseases Involving RNF213 Gene Mutations: Review.Semantic proximity Read ↗

Meta-analysis of genotype and phenotype studies to confirm the predictive role of the RNF213 p.R4810K variant for moyamoya disease.Semantic proximity Read ↗

Validation and Extension Study Exploring the Role of RNF213 p.R4810K in 2,877 Chinese Moyamoya Disease Patients.Semantic proximity Read ↗

[Precision Medicine for Moyamoya Disease].Semantic proximity Read ↗

RNF213 in moyamoya disease: Genotype-phenotype association and the underlying mechanism.Semantic proximity Read ↗

Role of Ring Finger Protein 213 in Moyamoya Disease.Semantic proximity Read ↗

Moyamoya Disease and Spectrums of RNF213 Vasculopathy.Semantic proximity Read ↗

Association of Genetic Variants With Moyamoya Disease in 13 000 Individuals: A Meta-Analysis.Semantic proximity Read ↗

Novel Susceptibility Loci for Moyamoya Disease Revealed by a Genome-Wide Association Study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.